SYNAPSE (1009.112.081): annual accounts, directors and company register

SYNAPSE

Ghent ·KBO/BCE: BE 1009.112.081

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Group	Expected	Actual
1	0.2%	0.2%
2	0.3%	0.5%
3	0.5%	0.6%
4	0.7%	0.8%
5	0.9%	0.9%
6	1.3%	1.5%
7	1.6%	1.8%
8	1.8%	1.8%
9	3.0%	3.1%
10	5.6%	6.2%

Line	2025	2024
Balance sheet: assets
Total assets`20/58`	141,333	44,922
Fixed assets`21/28`	3,159	2,946
Tangible fixed assets`22/27`	3,159	2,946
Furniture and vehicles`24`	3,159	2,946
Current assets`29/58`	138,174	41,976
Amounts receivable within one year`40/41`	942	125
Trade receivables`40`	-	125
Other amounts receivable`41`	942	-
Cash at bank and in hand`54/58`	117,164	27,483
Deferred charges and accrued income`490/1`	20,068	14,368
Balance sheet: equity and liabilities
Total equity and liabilities`10/49`	141,333	44,922
Equity`10/15`	127,632	31,747
Contributions`10/11`	5,000	5,000
Reserves`13`	122,632	26,747
Distributable reserves`133`	122,632	26,747
Amounts payable`17/49`	13,701	13,176
Amounts payable within one year`42/48`	12,996	13,176
Trade debts`44`	713	1,447
Suppliers`440/4`	713	1,447
Taxes, remuneration and social security`45`	1,375	2,626
Taxes`450/3`	1,375	2,626
Other amounts payable`47/48`	10,909	9,103
Accrued charges and deferred income`492/3`	705	-
Income statement
Gross operating margin`9900`	125,326	34,957
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets`630`	1,115	268
Other operating charges`640/8`	209	562
Operating profit (loss)`9901`	124,003	34,128
Financial charges`65/66B`	759	31
Recurring financial charges`65`	759	31
Profit (loss) for the period before taxes`9903`	123,243	34,097
Income taxes`67/77`	27,358	7,351
Profit (loss) for the period`9904`	95,885	26,747
Profit (loss) for the period to be appropriated`9905`	95,885	26,747
Appropriation of the result
Profit (loss) to be appropriated`9906`	95,885	26,747
Transfer to equity`691/2`	95,885	26,747
To other reserves`6921`	95,885	26,747
Document	PDF	PDF

Financial year	Type	Filed	Reference	Document
31-12-2025	micro format	27-07-2026	2026-00377826	PDF
31-12-2024	micro format	22-09-2025	2025-00511242	PDF

Line	2025	2024
EBITDA	125,117	34,396
Cash flow	97,000	27,014
Investment in fixed assets	1,328	3,214
Change in cash	89,681	-
Working capital	125,177	28,800
Solvency	90.3%	70.7%
Current ratio	10.63	3.19
Debt to equity	0.11	0.42
ROE	75.1%	84.3%
ROA	67.8%	59.5%
Interest coverage	over 100	over 100

Item	2025	2024
Tangible fixed assets	€1,328	€3,214
Depreciation and write-downs of the year	€1,115	€268

Overview

Lifetime

Key points

Result

Turnover

Liquidity

Checked score

Score breakdown

Comparable companies, two years later

Credit verdict

Signals

Board and ownership

Recent changes

Official details

Annual accounts 2025

Insights on SYNAPSE

Financials

Annual accounts 2025

Balance sheet

Change in equityin euro

Change in cashin euro

Filed annual accounts

Filings

Key figures and ratios

Investments

Insights on SYNAPSE

Board & ownership

Board

Mandates through the years

Control

Capital

Articles of association

Shareholders

Network & group

No group

Timeline

Timeline

History

Company details

Identity

Activities

Registered office and establishments

Buildings and parcels at the address

Location

Parcels